当前位置:首页 - 行情中心 - 傲农生物(603363) - 财务分析 - 资产负债表

傲农生物

(603363)

  

流通市值:73.29亿  总市值:89.02亿
流通股本:21.43亿   总股本:26.03亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金429,852,571.31697,570,126.52696,899,200.38820,185,758.72
  交易性金融资产11,002,734.841,112,832.61,208,843.641,603,396.35
  衍生金融资产1,859,200-86,0007,600
  应收票据及应收账款718,861,969.37509,906,019.38706,781,222.06546,998,307.4
  其中:应收票据-50,000--
        应收账款718,861,969.37509,856,019.38706,781,222.06546,998,307.4
  应收款项融资300,000300,000200,00050,000
  预付款项147,570,782.23155,474,017.9137,051,566.63152,712,232.93
  其他应收款合计867,524,148.94840,059,622.77898,309,345.59810,813,205.59
        应收股利2,587,982.852,587,982.852,587,982.852,587,982.85
  存货1,161,837,223.06955,400,828.99887,771,099.63905,898,171.16
  一年内到期的非流动资产---748,843.07
  其他流动资产172,193,200.73172,107,910.37193,773,704.81190,283,629.58
  流动资产合计3,511,001,830.483,331,931,358.533,522,080,982.743,429,301,144.8
非流动资产:
  长期股权投资108,497,368.59110,623,351.37121,555,769.57120,406,810.07
  其他权益工具投资5,508,186.615,749,593.854,218,892.314,416,343.97
  其他非流动金融资产16,556,64016,556,64037,356,64037,356,640
  投资性房地产114,017,492.49115,893,331.9149,188,153.0649,850,201.13
  固定资产2,952,562,038.583,022,063,527.313,172,510,148.633,264,431,046.72
  在建工程420,715,199.18421,801,478.26428,245,748.3462,631,587.77
  生产性生物资产354,208,374.83345,440,540.78318,671,660.46314,006,019.35
  使用权资产318,411,521.29324,468,937.22341,907,009.39353,993,264.32
  无形资产312,954,445.67315,958,304.24320,198,667.16327,393,564.36
  商誉337,744,304.77337,744,304.77357,209,598.98357,127,069.45
  长期待摊费用165,934,911.2167,818,000.63156,471,367.16151,211,774.08
  递延所得税资产136,837,863.9142,634,087.65179,466,806.16161,054,622.36
  其他非流动资产95,617,346.4883,253,280.83139,063,524.21137,171,708.45
  非流动资产合计5,339,565,693.595,410,005,378.825,626,063,985.395,741,050,652.03
  资产总计8,850,567,524.078,741,936,737.359,148,144,968.139,170,351,796.83
流动负债:
  短期借款319,697,500.27297,740,034.26366,228,929.98432,681,596.68
  衍生金融负债44,200673,68083,400-
  应付票据及应付账款1,589,698,049.971,410,227,277.661,296,371,918.331,362,590,449.32
  其中:应付票据24,524,211.3436,488,46821,922,259.4-
        应付账款1,565,173,838.631,373,738,809.661,274,449,658.931,362,590,449.32
  合同负债178,737,682.2138,275,293.96164,654,437.68173,852,981.29
  应付职工薪酬69,225,918.0187,986,782.674,345,493.4868,825,708.14
  应交税费19,258,123.7128,450,745.2924,382,975.217,177,486.49
  其他应付款合计1,002,564,858.881,022,628,644.931,045,866,482.881,083,916,511.93
  其中:应付利息31,307,675.6329,281,018.9227,725,766.0824,136,196.89
        应付股利12,532,0001,532,0004,900,0005,405,777.7
  一年内到期的非流动负债598,034,998.09579,575,063.24474,293,639.19453,392,603.02
  其他流动负债322,861.49380,877.58567,178.81533,013.58
  流动负债合计3,777,584,192.623,565,938,399.523,446,794,455.553,592,970,350.45
非流动负债:
  长期借款1,259,311,016.21,279,350,220.91,586,852,473.041,580,983,741.48
  租赁负债163,060,829.83172,833,269.17187,150,545.64197,329,206.59
  长期应付款--539,406.432,832,232.79
  预计负债31,790,220.2531,794,885.6927,574,748.661,285,106.46
  递延收益97,400,814.6299,641,153.59101,599,013.48103,759,157.2
  递延所得税负债11,883,309.5412,175,596.1712,468,931.6812,779,728.69
  非流动负债合计1,563,446,190.441,595,795,125.521,916,185,118.871,958,969,173.21
  负债合计5,341,030,383.065,161,733,525.045,362,979,574.425,551,939,523.66
所有者权益(或股东权益):
  实收资本(或股本)2,602,961,8262,602,961,8262,602,961,8262,602,961,826
  资本公积5,455,844,912.545,475,002,679.055,351,688,871.575,242,072,131.23
  减:库存股00--
  其他综合收益-49,178,670.74-48,940,364.65-50,474,167.35-50,279,816.84
  盈余公积68,356,991.5668,356,991.5668,356,991.5668,356,991.56
  未分配利润-4,980,237,125.28-4,966,907,349.52-4,630,595,616.79-4,683,727,804.49
  归属于母公司股东权益合计3,097,747,934.083,130,473,782.443,341,937,904.993,179,383,327.46
  少数股东权益411,789,206.93449,729,429.87443,227,488.72439,028,945.71
  股东权益合计3,509,537,141.013,580,203,212.313,785,165,393.713,618,412,273.17
  负债和股东权益合计8,850,567,524.078,741,936,737.359,148,144,968.139,170,351,796.83
公告日期2026-04-282026-04-232025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑